Also from this source

You just read:

NeuroSigma Announces Publication of Randomized Controlled Trial of eTNS for Treatment of Drug Resistant Epilepsy in the Leading Journal, Neurology®

News provided by

NeuroSigma, Inc.

Jan 30, 2013, 05:46 EST